PRETREATMENT SOLUBLE INTERLEUKIN-2 RECEPTOR LEVEL WAS A ROBUST PROGNOSTIC FACTOR IN FOLLICULAR LYMPHOMA IN RITUXIMAB ERA

Hematological Oncology ◽

10.1002/hon.2439_126 ◽

2017 ◽

Vol 35 ◽

pp. 369-370

Author(s):

Y. Kusano ◽

M. Yokoyama ◽

Y. Terui ◽

K. Hatake

Keyword(s):

Prognostic Factor ◽

Follicular Lymphoma ◽

Interleukin 2 ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1759054 ◽

2020 ◽

Vol 61 (9) ◽

pp. 2113-2121

Author(s):

Kenji Nozaki ◽

Hiroyuki Sugahara ◽

Shuji Ueda ◽

Jun Ishikawa ◽

Shigeo Fuji ◽

...

Keyword(s):

Follicular Lymphoma ◽

Interleukin 2 ◽

Newly Diagnosed ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor ◽

Pretreatment Serum

Download Full-text

Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP

Hematology ◽

10.1080/10245332.2017.1312204 ◽

2017 ◽

Vol 22 (9) ◽

pp. 521-526 ◽

Cited By ~ 7

Author(s):

Kento Umino ◽

Shin-ichiro Fujiwara ◽

Takashi Ikeda ◽

Yumiko Toda ◽

Shoko Ito ◽

...

Keyword(s):

Follicular Lymphoma ◽

Prognostic Value ◽

Interleukin 2 ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy

Anticancer Research ◽

10.21873/anticanres.13706 ◽

2019 ◽

Vol 39 (9) ◽

pp. 5115-5122

Author(s):

MASAHIDE YAMAMOTO ◽

KEISUKE TANAKA ◽

YOSHIHIRO UMEZAWA ◽

TOSHIKAGE NAGAO ◽

SHIGEO TOYOTA ◽

...

Keyword(s):

Follicular Lymphoma ◽

Management Strategy ◽

Interleukin 2 ◽

Initial Management ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy

Blood Cancer Journal ◽

10.1038/bcj.2017.96 ◽

2017 ◽

Vol 7 (9) ◽

pp. e614-e614 ◽

Cited By ~ 7

Author(s):

Y Kusano ◽

M Yokoyama ◽

Y Terui ◽

N Inoue ◽

A Takahashi ◽

...

Keyword(s):

Prognostic Factor ◽

Follicular Lymphoma ◽

Interleukin 2 ◽

Pretreatment Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era

Leukemia & Lymphoma ◽

10.3109/10428194.2013.850167 ◽

2014 ◽

Vol 55 (7) ◽

pp. 1584-1590 ◽

Cited By ~ 7

Author(s):

Vít Procházka ◽

Tomáš Papajík ◽

Edgar Faber ◽

Luděk Raida ◽

Zuzana Kapitáňová ◽

...

Keyword(s):

Follicular Lymphoma ◽

Interleukin 2 ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma

Leukemia & Lymphoma ◽

10.1080/10428194.2016.1190975 ◽

2016 ◽

Vol 58 (2) ◽

pp. 316-323 ◽

Cited By ~ 8

Author(s):

Kento Umino ◽

Shin-Ichiro Fujiwara ◽

Shoko Ito ◽

Kiyomi Mashima ◽

Daisuke Minakata ◽

...

Keyword(s):

Follicular Lymphoma ◽

Interleukin 2 ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden

International Journal of Hematology ◽

10.1007/s12185-021-03151-5 ◽

2021 ◽

Author(s):

Kenji Nozaki ◽

Hiroyuki Sugahara ◽

Shuji Ueda ◽

Jun Ishikawa ◽

Takahiro Karasuno ◽

...

Keyword(s):

Follicular Lymphoma ◽

Treatment Regimen ◽

Interleukin 2 ◽

Tumor Burden ◽

Advanced Stage ◽

Newly Diagnosed ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back

Cancer Immunology Immunotherapy ◽

10.1007/s002620050439 ◽

1998 ◽

Vol 45 (5) ◽

pp. 241-249 ◽

Cited By ~ 33

Author(s):

A. M. Berghella ◽

Patrizia Pellegrini ◽

Tiziana Del Beato ◽

Matteo Marini ◽

Ennio Tomei ◽

...

Keyword(s):

Colorectal Cancer ◽

Immune Response ◽

Interleukin 2 ◽

Cytokine Network ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement

The Journal of Dermatology ◽

10.1111/1346-8138.13792 ◽

2017 ◽

Vol 44 (7) ◽

pp. 789-797 ◽

Cited By ~ 34

Author(s):

Chuyen Thi Hong Nguyen ◽

Naotomo Kambe ◽

Izumi Kishimoto ◽

Ikuko Ueda-Hayakawa ◽

Hiroyuki Okamoto

Keyword(s):

Angiotensin Converting Enzyme ◽

Interleukin 2 ◽

Multiple Organ ◽

Organ Involvement ◽

Converting Enzyme ◽

Receptor Level ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text

Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U)

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-008-0440-0 ◽

2008 ◽

Vol 135 (1) ◽

pp. 53-59 ◽

Cited By ~ 27

Author(s):

Jun-ichi Kitagawa ◽

Takeshi Hara ◽

Hisashi Tsurumi ◽

Naoe Goto ◽

Nobuhiro Kanemura ◽

...

Keyword(s):

T Cell ◽

Prognostic Factor ◽

Cell Lymphoma ◽

Interleukin 2 ◽

T Cell Lymphoma ◽

Peripheral T Cell Lymphoma ◽

Interleukin 2 Receptor ◽

Soluble Interleukin 2 Receptor

Download Full-text